Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
7.75    0.00 (0.00%)
Bid:
7.50
Ask:
8.00
Spread: 0.50 (6.667%)
Market Cap: £38.16m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

European Processing & Offtake with Alkeemia

23 Jan 2026 07:57

RNS Number : 1522Q
Blencowe Resources PLC
23 January 2026
 

Date: 23 January 2026

 

Blencowe Resources Plc

("Blencowe" or the "Company"),

 

Blencowe Strengthens European Processing and Offtake Strategy with Alkeemia LOI

EU technical expert to enable 99.99% SPG purification via cleaner, non-China processing route

 

 

Blencowe Resources Plc (LSE: BRES) is pleased to announce it has signed a Letter of Intent ("LOI") with European specialist graphite processing organisation Alkeemia S.P.A. ("Alkeemia") to provide toll beneficiation and purification services for graphite produced from the Orom-Cross project in Uganda.

The graphite would be processed at a plant being developed by Alkeemia in Italy, delivering cleaner purified graphite than conventional Chinese processing routes and providing Blencowe with an alternative downstream pathway outside China.

This LOI builds on the successful test work announced on 15 January 2026, which demonstrated that Orom-Cross graphite can be purified to 99.99% carbon content, the highest commercially recognised purity, using Alkeemia's proprietary European purification technology, qualifying the product for sale into niche, high-value end markets where ultra-high purity is required.

 

Highlights

· Initial allocation of up to 1,000 tonnes per annum at Alkeemia's Italian facility, with the intention to increase volumes over time as both parties expand operations.

· Access to simpler, faster, lower-toxicity purification process compared to conventional Chinese processing methods.

· Cleaner purification technology that is increasingly required by European and US offtakers and funding bodies, particularly for battery and energy transition markets

· Establishes a non-China downstream processing pathway, aligned with increasing US and European focus on securing critical mineral supply chains

· Provides Blencowe with near-term, capital-light downstream optionality, alongside its longer-term plans to develop in-country SPG processing in Uganda.

· Strengthens Blencowe's ability to engage with European offtakers and funding bodies, where local processing and traceable supply chains are increasingly prioritised.

· Strengthens European-aligned and international supply chains for the delivery of high-purity graphite products into global markets.

 

The Company believes this LOI represents an important step in de-risking its downstream strategy while preserving flexibility as Orom-Cross advances towards production. European toll treatment provides Blencowe with the ability to access premium, high-purity graphite markets without committing to immediate large-scale downstream capital expenditure.

Blencowe and Alkeemia view this LOI as the first stage in establishing a longer-term commercial relationship with scope to expand both processing volumes and collaboration as Alkeemia develops additional capacity and Blencowe advances Orom-Cross.

The Company believes that establishing a European-based purification and toll treatment pathway also opens up potential access to European funding initiatives, where local processing, traceable supply chains and reduced reliance on Chinese-controlled processing routes are increasingly important criteria. The LOI with Alkeemia therefore strengthens Blencowe's positioning in ongoing discussions with European stakeholders across offtake, strategic partnerships and funding.

Blencowe is already an exclusive supplier of natural flake graphite into the EU SAFELOOP initiative, which is part of the European Union's €100 billion Project Horizon energy transition programme, further strengthening the Company's positioning within European battery and energy transition supply chains.

 

Cameron Pearce, Blencowe's Executive Chairman commented:

"This LOI with Alkeemia, represents a significant strategic step for Blencowe, providing a credible European purification pathway for Orom-Cross graphite using cleaner, innovative processing technology.

As Orom-Cross advances towards production and Alkeemia continues to develop its facilities in Italy, this relationship is expected to support increasing scale and to act as a platform to bring further European offtake opportunities into play. 

With China announcing export controls on lithium battery products, equipment and processing technologies, alternatives delivered through Alkeemia have the potential to play a substantial role in supporting the transition of international markets towards purified graphite products produced outside of China."

 

Lorenzo Di Donato, Alkemia CEO commented:

"We are pleased to formalise our collaboration with Blencowe through this Letter of Intent. Test work has confirmed that Orom-Cross graphite responds well to our purification process, achieving very high purity levels suitable for demanding niche end-user applications.

We see this as the beginning of a constructive partnership, with the potential to expand processing volumes over time and support the development of European-aligned graphite supply chains."

 

 

 

Issue of Equity

The Company has issued 500,000 ordinary shares to Minex in lieu of fees. Minex has been appointed as consultant to provides access to project financiers that have been reviewing the DFS. Also, the Company has granted Minex with 1,000,000 options at 10p for a period of 3 years.

The Company will make an application for 500,000 New Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange at 8.00 a.m. on 28 January 2026.

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 477,795,645 Ordinary Shares, each with one vote. The Company does not hold any Ordinary Shares in Treasury. On Admission, the total number of voting rights in the Company is expected to be 477,795,645 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

**ENDS**

 

 

For further information please contact:

 

Blencowe Resources Plc

www.blencoweresourcesplc.com

 

Sam Quinn (Director)

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Sasha Sethi (Investor Relations)

Tel: +44 (0) 7891 677 441

sasha.sethi@blencoweresourcesplc.com

Tavira Financial (Joint Broker)

 

Jonathan Evans

 

 

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

Oak Securities (Joint Broker)

 

Calvin Man /Mungo Sheehan / Jerry Keen

 

 

Tel: +44 (0)20 3973 3678

Twitter

https://twitter.com/BlencoweRes

LinkedIn

https://www.linkedin.com/company/72382491/admin/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKNBQOBKKCDB
Date   Source Headline
12th Jun 20264:35 pmRNSBlock Admission Six Monthly Return
4th Jun 20267:01 amRNS-ROak Securities Research Note Following DFS Update
2nd Jun 202610:45 amRNSExercise of Share Options
29th May 20267:00 amRNSOrom Cross Graphite DFS NPV10 up 15% to US$1.254bn
28th May 20267:04 amRNS-RAppointment of Joint Broker
26th May 202612:46 pmRNSHalf-year Financial Report
18th May 20267:00 amRNSBeehive Deposit Maiden JORC Resource
7th May 20267:36 amRNSRocket Component Testing Programme
30th Apr 20267:00 amRNSBeehive Final Assay Results
16th Apr 20267:00 amRNSBeehive Drilling Results
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
13th Mar 202612:57 pmRNSEXERCISE OF SHARE OPTIONS
6th Mar 20267:00 amRNSMaiden 16.9 Mt JORC Resource for Iyan Deposit
26th Feb 20262:57 pmRNSResult of AGM
24th Feb 20267:00 amRNSFinal Ilyan Drilling Results
20th Feb 202611:03 amRNSLong Term Incentive Programme
16th Feb 20267:00 amRNSUS AD/CVD Ruling Supports Non-China Supply
10th Feb 20267:00 amRNSHigh Value Synthetic Diamond Manufacture
6th Feb 20267:00 amRNSIyan - Further Significant Graphite Intercepts
2nd Feb 20267:00 amRNSIyan Deposit Delivers Multiple Intercepts over 30M
30th Jan 202611:29 amRNSAnnual Financial Report
23rd Jan 20267:57 amRNSEuropean Processing & Offtake with Alkeemia
15th Jan 20267:14 amRNSTestwork Confirms Highest Purity
13th Jan 202610:50 amRNSBlock Listing Application
13th Jan 20267:00 amRNS-RBroker Research Initiation
9th Jan 20267:00 amRNSBeehive Delivers 2 Standout +90 metre Intercepts
7th Jan 20269:17 amRNSDFS Performance Shares - Replacement
7th Jan 20268:25 amRNSExercise of Warrants
5th Jan 20264:14 pmRNSExercise of Warrants
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
23rd Dec 20257:00 amRNSBeehive Returns 92.55m @ 6.83% TGC from Surface
18th Dec 20257:00 amRNSFurther Strong Deep-Hole Results at Iyan
16th Dec 202511:47 amRNSExercise of Warrants
12th Dec 20257:00 amRNSExceptional Iyan Deep Hole Highlights Scale
11th Dec 20257:00 amRNSFundraise of £3m
9th Dec 20257:01 amRNSOfftake MOU with Yunasko Ltd.
9th Dec 20257:00 amRNSExercise of Warrants
8th Dec 20253:46 pmRNSExercise of Warrants
2nd Dec 20257:00 amRNSExercise of Share Options
1st Dec 20258:58 amRNS-RPresentation & Interview
1st Dec 20257:00 amRNSDFS Results Confirms Outstanding Economics
27th Nov 20257:00 amRNSJORC Resource Upgrade
25th Nov 202510:30 amRNSPublication of a Prospectus
17th Nov 20257:00 amRNSExercise of Warrants
13th Nov 202512:08 pmRNSExercise of Warrants
13th Nov 20258:30 amRNS-RResourcing Tomorrow Conference
12th Nov 202510:47 amRNSHolding(s) in Company
7th Nov 20258:00 amRNS-RCEO Interview

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.